Activation of Melatonin Receptors by Ramelteon Induces Cardioprotection by Postconditioning in the Rat Heart

Activation of melatonin receptors protects the heart against ischemia-reperfusion injury. Ramelteon, a clinically used drug for insomnia, acts via activation of melatonin receptors. We investigated whether ramelteon induces acute infarct size reduction by postconditioning. Male Wistar rats were randomized to 6 groups. Hearts were treated with melatonin and ramelteon at the beginning of reperfusion. The melatonin receptor inhibitor luzindole was administered with and without melatonin and ramelteon, respectively. Ramelteon reduced infarct size to the same extent as melatonin. Both effects were completely abolished by luzindole. The results show for the first time that ramelteon induces cardioprotection by postconditioning.

[1]  P. Pasdois,et al.  The role of succinate and ROS in reperfusion injury – A critical appraisal , 2017, Journal of molecular and cellular cardiology.

[2]  J. Mayo,et al.  Melatonin transport into mitochondria , 2017, Cellular and Molecular Life Sciences.

[3]  R. Reiter,et al.  Melatonin and mitochondrial function during ischemia/reperfusion injury , 2017, Cellular and Molecular Life Sciences.

[4]  H. Tabassum,et al.  Melatonin modulates permeability transition pore and 5-hydroxydecanoate induced KATP channel inhibition in isolated brain mitochondria. , 2016, Mitochondrion.

[5]  A. Hacimuftuoglu,et al.  A Review of Melatonin, Its Receptors and Drugs. , 2016, The Eurasian journal of medicine.

[6]  D. Mally,et al.  Impact of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels in Sildenafil-Induced Cardioprotection in Rats , 2015, PloS one.

[7]  M. Breschi,et al.  Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs , 2015, Medicinal research reviews.

[8]  A. Heinen,et al.  Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA–BKCa signaling pathway , 2014, Experimental Gerontology.

[9]  H. Rensing,et al.  Melatonin receptor antagonist luzindole is a powerful radical scavenger in vitro , 2008, Journal of pineal research.

[10]  Alexander H. Bentley,et al.  Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats* , 2008, Critical care medicine.

[11]  S. Ziegeler,et al.  MELATONIN PRETREATMENT IMPROVES LIVER FUNCTION AND HEPATIC PERFUSION AFTER HEMORRHAGIC SHOCK , 2007, Shock.

[12]  P. Ferdinandy,et al.  Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.

[13]  A. Lochner,et al.  Short‐ and long‐term effects of melatonin on myocardial post‐ischemic recovery , 2006, Journal of pineal research.

[14]  L. Becker Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.